Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other financing activities (2021 - 2023)

Historic Other financing activities for Journey Medical (DERM) over the last 3 years, with Q4 2023 value amounting to $380000.0.

  • Journey Medical's Other financing activities rose 34203.82% to $380000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $223000.0, marking a year-over-year increase of 420.56%. This contributed to the annual value of $50000.0 for FY2024, which is 8938.43% down from last year.
  • Latest data reveals that Journey Medical reported Other financing activities of $380000.0 as of Q4 2023, which was up 34203.82% from -$157000.0 recorded in Q4 2022.
  • In the past 5 years, Journey Medical's Other financing activities registered a high of $1.4 million during Q1 2021, and its lowest value of -$157000.0 during Q4 2022.
  • Over the past 3 years, Journey Medical's median Other financing activities value was $375500.0 (recorded in 2022), while the average stood at $431666.7.
  • Its Other financing activities has fluctuated over the past 5 years, first plummeted by 7257.95% in 2022, then skyrocketed by 34203.82% in 2023.
  • Journey Medical's Other financing activities (Quarter) stood at $464000.0 in 2021, then plummeted by 133.84% to -$157000.0 in 2022, then skyrocketed by 342.04% to $380000.0 in 2023.
  • Its Other financing activities stands at $380000.0 for Q4 2023, versus -$157000.0 for Q4 2022 and $371000.0 for Q1 2022.